Clinical Trial

Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients

Study acronym: MIRON-DFP
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The objective of this randomized, controlled pilot study is to determine the efficacy of Deferiprone to reduce the amount of free iron inside the hemorrhagic zone of myocardial infarction among hemorrhagic myocardial infarction patients.
Protocol Amendment History 1 change
notable Primary completion moved earlier: 2029-08-31 -> 2029-03-31 2026-04-04
Trial Details
NCT Number NCT05604131
Lead Sponsor Rohan Dharmakumar
Collaborators: Minneapolis Heart Institute
Conditions Acute Myocardial Infarction Type 1
Enrollment 89 participants
Start Date 2022-11-08
Primary Completion 2029-03-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-08